Oxime@Zirconium-Metal-Organic Framework Hybrid Material as a Potential Antidote for Organophosphate Poisoning.


Journal

Inorganic chemistry
ISSN: 1520-510X
Titre abrégé: Inorg Chem
Pays: United States
ID NLM: 0366543

Informations de publication

Date de publication:
03 Apr 2023
Historique:
medline: 4 4 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

A novel material with dual activity toward organophosphate (OP) poisoning, based on Zr-MOF-808 and neutral oxime RS69N, has been prepared. The hybrid material has a significant drug payload (5.2 ± 0.9 oxime to MOF-808 molar ratio) and shows a sustained oxime release in simulated physiological media, leading to the successful reactivation of OP-inhibited acetylcholinesterase. At the same time, the hybrid system presents an efficient and moderately fast removal rate of a toxic organophosphorus model compound (diisopropylfluorophosphate) from simulated physiological media (

Identifiants

pubmed: 36939843
doi: 10.1021/acs.inorgchem.3c00121
pmc: PMC10074384
doi:

Substances chimiques

Oximes 0
Antidotes 0
Cholinesterase Reactivators 0
Metal-Organic Frameworks 0
Zirconium C6V6S92N3C
Acetylcholinesterase EC 3.1.1.7
Cholinesterase Inhibitors 0
Organophosphorus Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5049-5053

Références

Clin Med Res. 2007 Mar;5(1):71-82
pubmed: 17456837
J Biol Chem. 2012 Apr 6;287(15):11798-809
pubmed: 22343626
Inorg Chem. 2022 Jan 24;61(3):1512-1520
pubmed: 34969248
ACS Appl Mater Interfaces. 2021 Feb 17;13(6):7004-7020
pubmed: 33554591
Biochem Pharmacol. 2004 Dec 1;68(11):2237-48
pubmed: 15498514
Nanomaterials (Basel). 2017 Oct 12;7(10):
pubmed: 29023426
BMC Public Health. 2020 Dec 7;20(1):1875
pubmed: 33287770
Lancet. 2008 Feb 16;371(9612):597-607
pubmed: 17706760
Lancet. 2006 Dec 16;368(9553):2136-41
pubmed: 17174705
ACS Appl Mater Interfaces. 2022 Jun 2;:
pubmed: 35653699
Chem Soc Rev. 2022 Jan 24;51(2):464-484
pubmed: 34985082
Chemosphere. 2020 Aug;253:126646
pubmed: 32276120
Inorg Chem. 2020 Nov 16;59(22):16160-16167
pubmed: 33151071
Nat Rev Neurosci. 2001 Apr;2(4):294-302
pubmed: 11283752
Arch Toxicol. 2020 Jul;94(7):2275-2292
pubmed: 32506210

Auteurs

Lydia González (L)

Departamento de Química Inorgánica, Universidad de Granada, Avenida Fuentenueva S/N, Granada 18071, Spain.

Javier D Martín-Romera (JD)

Departamento de Química Inorgánica, Universidad de Granada, Avenida Fuentenueva S/N, Granada 18071, Spain.

Purificación Sánchez-Sánchez (P)

Departamento de Química Inorgánica, Universidad de Granada, Avenida Fuentenueva S/N, Granada 18071, Spain.

Jorge A R Navarro (JAR)

Departamento de Química Inorgánica, Universidad de Granada, Avenida Fuentenueva S/N, Granada 18071, Spain.

Elisa Barea (E)

Departamento de Química Inorgánica, Universidad de Granada, Avenida Fuentenueva S/N, Granada 18071, Spain.

Carmen R Maldonado (CR)

Departamento de Química Inorgánica, Universidad de Granada, Avenida Fuentenueva S/N, Granada 18071, Spain.

Francisco J Carmona (FJ)

Departamento de Química Inorgánica, Universidad de Granada, Avenida Fuentenueva S/N, Granada 18071, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH